Story

Sanofi Options Trading Skews Bearish as Shares Fall Nearly 4%

ENTHMSVIIDZHZH-TWJAKOHI
Oct 2, 20262 min read
Sanofi Options Trading Skews Bearish as Shares Fall Nearly 4%

Summary

Options activity in Sanofi surged with a strong bearish bias as the stock dropped 3.8%, though complex long-term trades suggest some investors are positioning for a potential rebound.

Text size
Background

Options traders heavily favored bearish contracts on Sanofi SA (SASY) during a session that saw the pharmaceutical company's shares fall 3.8% to €70.32. The activity was marked by a high volume of puts, indicating significant demand for downside protection or speculative bearish bets.

A Surge in Bearish Bets

Total options volume reached 10,583 contracts, with a lopsided mix that underscored the negative sentiment, according to Bloomberg-compiled data. Puts outpaced calls by a significant margin, creating a put/call ratio of approximately 2.4x.

Key trading activity included:

  • 7,439 put contracts traded, representing about 70% of the day's total options volume.
  • 3,144 call contracts changed hands.

The most active single line was the December 18, 2026 €80 put, which saw 2,000 contracts traded. With the strike price roughly 14% above the stock's current level, these deep in-the-money puts likely represent hedging activity by shareholders or a significant directional bet on further declines.

Complex Trades Signal Nuanced Views

Sample IUX Markets – In-articleAd

Despite the overwhelmingly bearish surface-level data, some large and complex trades suggest a more varied long-term outlook. A notable trade structure involving the December 21, 2029 expiration saw 1,200 contracts change hands, split evenly between the €80 call and the €70 put. This pattern resembles a risk reversal, a strategy that can be used to position for a recovery within a defined range. The high volume relative to open interest suggests these are likely new positions.

Separately, fresh positioning was evident in a shorter-dated contract, the November 20, 2026 €72 call. Over 1,000 of these contracts were traded against a previous open interest of just one, signaling a new bet on a near-term rebound.

Volatility Remains Muted

While a nearly 4% drop is notable for a defensive stock like Sanofi, the options market did not signal widespread alarm. Three-month implied volatility saw only a minor increase, rising just 0.24 points to 26.31%.

Similarly, the skew, which measures the premium of downside puts over equidistant upside calls, remained relatively stable. This muted reaction in volatility metrics suggests that while traders were actively hedging, the market is not pricing in expectations for a dramatic increase in future price swings.

Read next

More on Stocks
Back to latest news

LATEST